Dr. Christoph Schmölzer

• Leading product management team in US & EU for oligonucleotide and mRNA therapeutics materials. • Developing and implementing strategy for realignment of business segment. • Identifying and introducing new product opportunities, strengthening the existing product portfolio and brand positioning. • Marketing and competitive strategy to outperform market growth.

• Implementing and standardizing real-time, automated operational performance metrics. • End-to-end governance and decision making from opportunity to commercialization. • Internal and external single point of contact for assigned programs. • Manage oversight of recovery plans and escalations to achieve OTIF and RFT goals. • Leading strategic, operational aspects of programs to ensure timely, coordinated, pro-active risk mitigated delivery of projects and services.

• Managing 20 to 25 global accounts ranging from small/emerging to large pharma Clients from early-phase/pre-clinical stage to late-phase and commercial across five API sites. • Commercial responsibility from quotation, contract negotiation to execution and to develop a long-term business plan to increase business. • Coordinating and steering resources with competing priorities at the site level. • Developing critical skills in talents at production sites.

• Providing market and competitive intelligence to senior leadership to support strategic decisions. • Key member in annual planning and strategic initiatives. • Supporting portfolio optimization via strategic insights to projects (e.g., clinical trial performance, volume at maturity assessments) • Responsible for onboarding and introduction of new hires during maternity leave of Director SBI.